Heinrich Graetz : Abhandlungen zu seinem 100. Geburtstage (31. Oktober 1917)

hrsg. von M. Brann

Aus Heinrich Heine's Ahnensaal

von David Kaufmann

Heinrich Graetz

Sch. Gorelik

Heinrich Graetz : eine Würdigung d. Historikers u. Juden zu seinem 100. Geburtstage 31. Okt. 1917 (21. Cheschwan)

von Josef Meisl

Heinrich Graetz : a centenary

by Gotthard Deutsch

Heinrich Graetz : a memoir

by Philipp Bloch

Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.

RATIONALE Early reperfusion in patients experiencing acute ischemic stroke is critical, especially for patients with large vessel occlusion who have poor prognosis without revascularization. Solitaire™ stent retriever devices have been shown to immediately restore vascular perfusion safely, rapidly, and effectively in acute ischemic stroke patients with large vessel occlusions. AIM The aim of the study was to demonstrate that, among patients with large vessel, anterior circulation occlusion who have received intravenous tissue plasminogen activator, treatment with Solitaire revascularization devices reduces degree of disability 3 months post stroke. DESIGN The study is a global multicenter, two-arm, prospective, randomized, open, blinded end-point trial comparing functional outcomes in acute ischemic stroke patients who are treated with either intravenous tissue plasminogen activator alone or intravenous tissue plasminogen activator in combination with the Solitaire device. Up to 833 patients will be enrolled. PROCEDURES Patients who have received intravenous tissue plasminogen activator are randomized to either continue with intravenous tissue plasminogen activator alone or additionally proceed to neurothrombectomy using the Solitaire device within six-hours of symptom onset. STUDY OUTCOMES The primary end-point is 90-day global disability, assessed with the modified Rankin Scale (mRS). Secondary outcomes include mortality at 90 days, functional independence (mRS ≤ 2) at 90 days, change in National Institutes of Health Stroke Scale at 27 h, reperfusion at 27 h, and thrombolysis in cerebral infarction 2b/3 flow at the end of the procedure. ANALYSIS Statistical analysis will be conducted using simultaneous success criteria on the overall distribution of modified Rankin Scale (Rankin shift) and proportions of subjects achieving functional independence (mRS 0-2).

Herrn und Frau Heinrich Brisbois zur Goldenen Hochzeit : Dienstag den 27. August 1878

Friedrich Stoltze

Frankfurt a. M. im Jahre 1805 : eine historische Studie ; dem Bankhause Jacob S. H. Stern zur Feier seines 100jährigen Bestehens 1805 - 1905 als Jubiläumsgabe überr. von Heinrich Emden

verfasst im Auftrag von Heinrich Emden. Rev. von Kracauer [[Elektronische Ressource]]

Continuation und fernere Beobachtung Deß Anno 1680. den 16. (26.) Decemb. zum erstenmal erschienenen Grossen Cometen

observiret und in Kupfer gebracht von Petro Neutard ...

Rede des Abgeordneten Heinrich Simon aus Breslau, gehalten in der Sitzung der deutschen Reichsversammlung vom 4. Januar 1849: Heinrich Simon von Breslau: Meine Herren! Als die preußischen Verhältnisse am 14. und 20. November zur Debatte kamen ...

Welsch (Projektbearbeiter): Antrag des Abgeordneten Simon auf eine Erklärung der Deutschen Nationalversammlung, daß die preußische oktroyierte Verfassung die Rechte der preußischen Bevölkerung verletze. Hintergrund: Auflösung der preußischen Nationalversammlung und Oktroyierung einer Verfassung am 5. Dez. 1848

Mechanical thrombectomy in acute ischemic stroke: Consensus statement by ESO-Karolinska Stroke Update 2014/2015, supported by ESO, ESMINT, ESNR and EAN

The original version of this consensus statement on mechanical thrombectomy was approved at the European Stroke Organisation (ESO)-Karolinska Stroke Update conference in Stockholm, 16-18 November 2014. The statement has later, during 2015, been updated with new clinical trials data in accordance with a decision made at the conference. Revisions have been made at a face-to-face meeting during the ESO Winter School in Berne in February, through email exchanges and the final version has then been approved by each society. The recommendations are identical to the original version with evidence level upgraded by 20 February 2015 and confirmed by 15 May 2015. The purpose of the ESO-Karolinska Stroke Update meetings is to provide updates on recent stroke therapy research and to discuss how the results may be implemented into clinical routine. Selected topics are discussed at consensus sessions, for which a consensus statement is prepared and discussed by the participants at the meeting. The statements are advisory to the ESO guidelines committee. This consensus statement includes recommendations on mechanical thrombectomy after acute stroke. The statement is supported by ESO, European Society of Minimally Invasive Neurological Therapy (ESMINT), European Society of Neuroradiology (ESNR), and European Academy of Neurology (EAN).